pharmaphorum
DECEMBER 18, 2022
However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. This, once again, leads to abandonment caused by patient out-of-pocket costs as a critical driver in non-adherence.
PM360
AUGUST 9, 2022
Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. For biopharma, success in this space will require integrated models that are significantly different than what has been used with historic medicines. In oncology, it’s 47% less.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Impetus Digital
MARCH 15, 2024
Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).
Legacy MEDSearch
MAY 19, 2023
Through this collaboration, healthcare providers are able to access clinically relevant heart rhythm analyses and actionable reports via PaceMateLIVE to monitor at-risk patients; identify underlying arrhythmias, including atrial fibrillation (AF); and drive improvements to patient care and clinical outcomes.
PM360
APRIL 22, 2024
With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience. In one survey, only 12% of HCPs said they felt biopharma companies are very effective at providing HCP education and training to them.
Clarivate
MARCH 14, 2024
Research is raising concerns about PFAS use Similarly, PFAS (per- and polyfluoroalkyl substances) in pharmaceutical packaging have recently come under scrutiny, leading to significant regulatory changes. With Europe taking the lead in introducing draft regulations on PFAS, will other countries and regions implement their own regulations?
PM360
AUGUST 24, 2023
As professionals with more than a half-century between us working in biopharma and diagnostics marketing and communications from the corporate (Ayaz Malik) and agency (Sandra Stahl) sides, we believe nurturing multigenerational teams is an especially powerful yet underutilized strategy for our industry.
Expert insights. Personalized for you.
77 
Let's personalize your content